Ovarian cancer vaccine shows promising results in human study

Immunotherapy has gained ground against a stubborn opponent: ovarian cancer. A personalized cancer vaccine is safe an...

Posted: Apr 12, 2018 6:38 AM
Updated: Apr 12, 2018 6:38 AM

Immunotherapy has gained ground against a stubborn opponent: ovarian cancer. A personalized cancer vaccine is safe and may lengthen the lives of ovarian cancer patients, a small clinical trial found.

The research, published Wednesday in the journal Science Translational Medicine, showed "significantly higher" overall survival at two years among patients who received the vaccine, compared with patients who did not.

85% of ovarian cancer patients relapse after treatment

"Personalized vaccines" inspire immune systems to fight cancer, a trial found

Ovarian cancer is a "silent killer" because often it goes unnoticed until it is diagnosed at a late stage. Treated with surgery followed by chemotherapy, most patients -- 85% -- relapse and ultimately develop resistance to the chemo. At this point, they run out of treatment options.

Still, scientists are hopeful based on the fact that a subset of patients shows an immune response to their cancer. Generally, these patients have better survival rates than those whose immune systems don't react in the same way.

A vaccine, then, might be able to trigger and boost the immune system and increase the survival rates of patients, said Dr. Lana Kandalaft, senior author of the new study and an adjunct assistant professor at the University of Pennsylvania Perelman School of Medicine.

Personalized medicine

Testing this hypothesis, Kandalaft and her colleagues created "personalized" vaccines for 25 patients diagnosed with advanced recurrent ovarian cancer. The women had recurrent advanced epithelial ovarian cancer, which has an average five-year survival rate of 17%, according to the American Cancer Society.

The scientists made each unique vaccine using a patient's tumor (stored and preserved before surgery) and dendritic cells from her blood.

Within the immune system, dendritic cells act as clever spies. Their mission is to identify foreign invaders lurking in the shadowy interfaces between our bodies and the environment: the lining of our airways, for example, and the surface of our intestines. Once they discover a virus or a dangerous toxin, dendritic cells will capture and display fragments of the invader on their surfaces and then travel deep into the lymph nodes, where the immune system's killer T cells reside.

Here, a simple introduction -- a knowing glance among friends -- takes place. The newly accessorized dendritic cells trigger the T cells to launch an attack in an attempt to destroy the invaders.

For the study, some patients received the personalized vaccine alone, and others received it in combination with either one or two chemo drugs (bevacizumab and cyclophosphamide).

"The patients who received the vaccine mounted an immune response against their own tumors," Kandalaft said in a statement. She described the immune response as "an increased number of T cells which were specific to the tumor and were able to kill tumors."

'Promising'

Each of the 25 patients received, on average, 16 vaccine shots over the course of the study and none experienced severe side effects from the vaccine.

Overall two-year survival was highest among responsive study patients who received the vaccine and two chemo drugs: Seventy-eight percent of vaccinated patients who also received the chemo drugs survived two years, compared with just 44% of patients who received the drugs but no vaccine.

Still, one vaccine-only patient remained in remission for five years after the study; prior to the study, her cancer had recurred twice after chemotherapy.

Dr. Otis Brawley, chief medical officer of the American Cancer Society, said the new study amounts to "good science" that "clearly justifies a larger clinical trial."

However, Brawley, who was not involved in the research, remains cautious of this "designer vaccine."

"Survival analysis is prone to some biases, which can mislead even the most experienced of clinical trialists," he said. The public "often wants to pass up better-proven conventional therapy for an unknown in immunotherapy."

Overall, Brawley is hopeful for immunotherapy as a treatment for ovarian cancer. "This methodology has been looked at in prostate cancer and may be useful in other diseases."

Going forward, Kandalaft and her colleagues will be pursuing larger studies of these vaccines. The results of the current study, designed to address safety and funded by National Institutes of Health, were "promising, albeit preliminary," she said.

Terre Haute
Overcast
70° wxIcon
Hi: 86° Lo: 68°
Feels Like: 70°
Robinson
Overcast
67° wxIcon
Hi: 84° Lo: 66°
Feels Like: 67°
Indianapolis
Broken Clouds
70° wxIcon
Hi: 87° Lo: 66°
Feels Like: 70°
Rockville
Overcast
67° wxIcon
Hi: 85° Lo: 65°
Feels Like: 67°
Casey
Broken Clouds
69° wxIcon
Hi: 85° Lo: 68°
Feels Like: 69°
Brazil
Overcast
70° wxIcon
Hi: 86° Lo: 67°
Feels Like: 70°
Marshall
Overcast
70° wxIcon
Hi: 86° Lo: 67°
Feels Like: 70°
Afternoon showers possible.
WTHI Planner
WTHI Temps
WTHI Radar

WTHI Events

 

Illinois Coronavirus Cases

(Widget updates once daily at 7 p.m. CT)

Confirmed Cases: 196699

Reported Deaths: 7846
CountyConfirmedDeaths
Cook1119484928
Lake12741446
DuPage12312520
Kane9803305
Will9315344
St. Clair4028161
Winnebago3784131
McHenry3218114
Madison263476
Kankakee178768
Rock Island175636
Champaign168619
Peoria163035
Kendall137923
Unassigned1358209
Sangamon127433
DeKalb93830
LaSalle78324
Boone76623
Jackson72219
McLean65515
Macon64123
Tazewell5918
Adams5425
Coles48720
Randolph4707
Clinton41117
Ogle4115
Williamson4096
Whiteside35917
Stephenson3306
Grundy3265
Union32423
Monroe31813
Knox3031
Jefferson29019
Morgan2686
Iroquois26511
Henry2481
Vermilion2362
Cass23111
Bureau2153
Franklin1910
Warren1910
Perry1841
Macoupin1813
Lee1731
Montgomery1697
Effingham1621
Marion1610
Woodford1523
McDonough14615
Christian1434
Saline1322
Jo Daviess1271
Douglas1222
Logan1220
Livingston1162
Jersey1152
Pulaski941
Clark832
Shelby801
Mercer764
Moultrie740
Johnson690
White690
Fayette673
Washington670
Piatt630
Bond623
Hancock621
Wayne621
Carroll594
Jasper597
Greene580
Cumberland573
Menard560
Mason530
Gallatin512
Lawrence500
Ford492
Massac400
Alexander370
Wabash350
Fulton340
De Witt330
Crawford290
Edgar290
Hamilton290
Marshall270
Clay230
Pike230
Scott210
Richland200
Edwards180
Hardin180
Schuyler180
Brown140
Henderson130
Putnam130
Calhoun100
Pope90
Stark70
Out of IL00

Indiana Coronavirus Cases

(Widget updates once daily at 8 p.m. ET)

Confirmed Cases: 74992

Reported Deaths: 3044
CountyConfirmedDeaths
Marion15963725
Lake7632275
Elkhart488385
Allen3937163
St. Joseph354682
Hamilton2803104
Vanderburgh199713
Hendricks1901108
Cass17969
Johnson1767118
Porter133839
Clark124447
Tippecanoe122111
Madison98765
LaPorte92130
Howard90565
Kosciusko86212
Bartholomew80147
Floyd79146
Marshall79022
Monroe75930
Delaware73852
Dubois70012
Noble68429
Boone68346
Hancock67038
Vigo66810
Jackson5885
Warrick58630
LaGrange55910
Shelby55827
Grant52830
Dearborn50828
Morgan48334
Clinton4403
Henry38520
Wayne37710
White37210
Montgomery35421
Lawrence35027
Harrison34123
Decatur33832
Putnam2908
Miami2742
Daviess27320
Scott26810
Greene25134
Jasper2452
Franklin24314
DeKalb2354
Gibson2284
Jennings22612
Steuben2113
Ripley2087
Carroll1932
Fayette1907
Perry18612
Starke1787
Posey1770
Orange17324
Wells1712
Wabash1703
Fulton1692
Jefferson1652
Knox1590
Whitley1546
Tipton14311
Washington1421
Spencer1363
Sullivan1341
Clay1245
Huntington1243
Randolph1234
Newton11810
Adams1022
Jay920
Owen911
Pulaski831
Rush804
Brown741
Fountain742
Blackford652
Ohio655
Benton620
Pike560
Vermillion550
Parke521
Switzerland520
Crawford450
Martin450
Union410
Warren231
Unassigned0206